LOWE

Product · Developer tool by Recursion

Proprietary drug discovery software for navigating biological and chemical complexity.

LOWE is Recursion's proprietary drug discovery software that provides a scientist-facing interface for the Recursion Operating System. It enables researchers to explore biological maps, identify therapeutic targets, and design optimized molecules within a unified digital and physical workflow.

Launched
2024-01-08

Category: Drug Discovery

  • Unveiled at the 2024 J.P. Morgan Healthcare Conference
  • Primary interface for the Recursion Operating System
  • Supports target discovery and precision drug design
  • Bridges digital analysis and physical lab automation

Overview

LOWE is a proprietary drug discovery software tool developed by Recursion to empower scientists in navigating the complexities of biology and chemistry. Unveiled in early 2024, the software serves as a primary interface for interacting with the Recursion Operating System and its extensive biological maps. It allows researchers to leverage AI-driven insights to identify novel therapeutic targets and design optimized molecules more efficiently. LOWE is designed to bridge the gap between digital analysis and physical lab automation, providing a unified workspace for the discovery process. The tool is used internally and has been provided to select partners to advance their drug discovery programs.

Drug Discovery Capabilities

  • Recursion OS Interface: The software serves as a primary interface for scientists to interact with the Recursion Operating System and its biological maps.
  • Target Discovery Exploration: LOWE enables the exploration of complex biological relationships to identify novel therapeutic targets.
  • Precision Drug Design: The tool supports the design and optimization of chemical compounds within an integrated digital environment.

Use cases

  • Scientists use the interface to interact with the Recursion OS and its vast biological maps for target identification.
  • Researchers explore complex biological relationships to discover novel therapeutic targets for various diseases.
  • Drug developers design and optimize chemical compounds within an integrated digital and physical lab environment.

Added by AntSpace from public sources (recursion.com).

Related

More products by Recursion